Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Findings, Diagnostic Accuracy, Treatment, and Outcomes in Freeman-Burian Syndrome and Similar-appearing Arthrogryposis Syndromes: a Cross-sectional, Non-randomized Study

NCT05419245 is registered in ClinicalTrials.gov with Dufresne, Craig, MD, PC as lead sponsor.

NCT NCT05419245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05419245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Findings, Diagnostic Accuracy, Treatment, and Outcomes in Freeman-Burian Syndrome and Similar-appearing Arthrogryposis Syndromes: a Cross-sectional, Non-randomized Study
Lead sponsor
Dufresne, Craig, MD, PC
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
December 31, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthrogryposis distal type 1, arthrogryposis distal type 3, freeman-burian syndrome, freeman-sheldon syndrome, freeman-sheldon syndrome variant, gordon syndrome, sheldon-hall syndrome, whistling face syndrome